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Abstract: Natural products are an important source of novel investigational compounds in drug
discovery. Especially in the field of antibiotics, Actinobacteria have been proven to be a reliable source
for lead structures. The discovery of these natural products with activity- and structure-guided
screenings has been impeded by the constant rediscovery of previously identified compounds.
Additionally, a large discrepancy between produced natural products and biosynthetic potential
in Actinobacteria, including representatives of the order Pseudonocardiales, has been revealed using
genome sequencing. To turn this genomic potential into novel natural products, we used an
approach including the in-silico pre-selection of unique biosynthetic gene clusters followed by
their systematic heterologous expression. As a proof of concept, fifteen Saccharothrix espanaensis
genomic library clones covering predicted biosynthetic gene clusters were chosen for expression in two
heterologous hosts, Streptomyces lividans and Streptomyces albus. As a result, two novel natural products,
an unusual angucyclinone pentangumycin and a new type II polyketide synthase shunt product
SEK90, were identified. After purification and structure elucidation, the biosynthetic pathways
leading to the formation of pentangumycin and SEK90 were deduced using mutational analysis of
the biosynthetic gene cluster and feeding experiments with 13C-labelled precursors.
Keywords: angucyclinone; heterologous expression; natural products; Actinobacteria; biosynthesis
1. Introduction
Actinobacteria, especially Streptomyces, represent one of the most important sources of natural
products [1]. During recent decades, their discovery in Actinobacteria was significantly slowed due to
re-isolation of known compounds in activity- and structure-guided screenings [2,3]. As an early solution
for the rediscovery issue, natural product databases have been created. Metabolic profiles recorded with
high performance liquid chromatography coupled with high-resolution mass spectrometry (LC-HRMS)
can be compared with information stored in these databases. This process, known as dereplication,
is problematic due to it being time consuming and error prone [4]. An additional problem of this
“compound first” approach is the need for laborious studies in order to identify the biosynthetic
gene clusters (BGCs) responsible for the production of the isolated compounds. This information is
essential to elucidate the biosynthetic pathway, which helps researchers to increase and modify the
production of identified natural products [5]. In contrast, the “cluster to compound” approach aims to
obtain new natural products after cloning and expression of a BGC of interest in heterologous hosts.
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This approach became increasingly reasonable due to the low cost of next-generation sequencing [6],
which has resulted in a flood of genomic information [7]. It has been shown that Streptomyces contain
an average of 21.9 BGCs per genome, with 40–48% of these BGCs being unique [8,9]. The “cluster to
compound” approach aims to tap into this genomic potential and offers decisive advantages over the
“compound first” approach. First, genome analysis and BGC prediction tools such as antiSMASH [10]
offer automated cluster homology comparisons within hours. In turn, this allows cataloguing and
prioritization of BGCs with unique features. Second, the utilization of optimized heterologous hosts
and the expression of BGCs from genomic libraries offer advantages over the use of native producing
strains [11–14]. Furthermore, the produced compounds can be identified by a simple comparison of
the metabolic profiles from the heterologous host with and without the expressed BGCs [11].
The aim of the presented study was to assess the untapped potential for the production of secondary
metabolites hidden in the genomes of Actinobacteria and to identify their biosynthetic pathways [8].
To achieve this goal, a widely applicable workflow was developed (Figure 1). This workflow includes
the analysis of genome sequences utilizing algorithms such as antiSMASH [15] and PRISM [16],
the construction of a sequenced genomic library, in silico pre-selection and expression of the selected
BGCs in optimized heterologous hosts followed by the identification, isolation and characterization
of natural products and their biosynthetic pathways. To challenge the applicability of the designed
approach, we aimed to express BGCs from a strain of Actinobacteria that is more distantly related to
commonly used heterologous Streptomyces hosts. The large-scale analysis by Doroghazi and co-authors
revealed that the order of Pseudonocardiales has an average of 19.8 BGCs per genome [8]. The strain
Saccharothrix espanaensis, discovered by Labeda and Lechevalier in 1989 [17], belongs to the order
of Pseudonocardiales, harboring all of the desired elements to prove the potential of our approach.
This strain has a 9.3 Mbp genome containing at least 31 antiSMASH-predicted BGCs [18]. Due to the
strain being poorly genetically tractable, any genetic manipulations are almost impossible. Furthermore,
only a single group of polysaccharide natural products, saccharomicins [19], is known to be produced
by S. espanaensis.
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Figure 1. Workflow for the identification of novel natural products using genome mining.
As proof of concept, we report the discovery of two novel natural products which were obtained by
applying the proposed genome mining approach. Neither of the isolated compounds were detectable
in the metabolic profile of S. espanaensis. Additionally, we were able to elucidate the biosynthesis of
both compounds using the available information about the BGC architecture, mutational analysis and
feeding experiments with labelled precursors.
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2. Materials and Methods
2.1. General Experimental Procedures
All oligonucleotides, plasmids and strains used in this work can be found in Tables S1 and S2.
Standard procedures for Escherichia coli (transformation and plasmid preparations) were performed
as described by Sambrook [20]. All BACs of the genomic library of S. espanaensis were isolated
with the BACMAXTM DNA purification kit (Lucigen, Middleton, WI, USA). All E. coli cultures were
cultivated at 37 ◦C at 180 rpm in LB-Lennox (5 g yeast extract, 10 g tryptone, 5 g NaCl and 1000 mL
H2Odest; pH = 7.2). For DNA fragment amplification, Dream Taq polymerase (Thermo Fisher Scientific,
Waltham, MA, USA) was used. DNA fragments were purified from agarose gels using the QIAquick
Gel Extraction Kit (Qiagen, Germany). Intergeneric conjugation between Streptomyces and E. coli was
performed as described by Kieser [21] on MS agar (20 g soya flour, 20 g agar, 20 g mannitol and 1000 mL
H2O with nalidixic acid 30 µg/mL for donor suppression) plates using E. coli PUB307 as donor strain.
Standard DNA manipulations (ligation, polymerase chain reactions and endonuclease digestion) were
performed according to the corresponding manufacturer’s protocol. All Streptomyces were cultivated
in 15 mL TSB (17 g Tryptone, 3 g Peptone, 5 g NaCl, 2.5 g K2HPO4, 2.5 g glucose and 1000 mL H2Odest;
pH = 7.2) in a 100-mL flask (4 baffles; 5 g glass beads), inoculated from spores of the corresponding
Streptomyces from an MS plate. After 24 h for S. albus and 72 h for S. lividans, 50 mL of the corresponding
production medium (SG medium (20 g glucose, 5 g yeast extract, 10 g bactosoytone, 2 g CaCO3 and
1000 mL H2Odest; pH = 7.2); DNPM medium (dextrin 40 g, soytone 7.5 g, fresh yeasts 5 g, MOPS 21 g
and 1000 mL H2Odest; pH = 6.8); TSB medium; SGG medium (10 g starch, 10 g glycerol, 2.5 g corn
steep solids, 5 g Peptone, 2 g yeast extract, 1 g NaCl, 3 g CaCO3 and 1000 mL H2Odest, pH = 7.2)) was
inoculated with 1 mL of the seed culture in a 500-mL flask (3 baffles, 10 g glass beads) and incubated
for 72–164 h at 180 rpm and 29 ◦C. Production optimization steps were carried out by adjustment of
different parameters (growth time, pH, medium, extracting solvent, addition of XAD -16 Amberlite
(2 g/100 mL) after 72 h). The optimization steps were monitored using HPLC-MS. When needed,
media were supplemented with the following antibiotics: apramycin 50 µg/mL, hygromycin 50 µg/mL,
kanamycin 100 µg/mL and nalidixic acid 30 µg/mL.
All HPLC-MS spectra were recorded on a Dionex Ultimate 3000 (Thermo Fisher Scientific,
Waltham, MA, USA) coupled with an AmaZon ETD SL speed, Apollo II ESI (Bruker, Billerica, MA,
USA) on a Waters BEH C18 column (100 × 2.1 mm, 1.7 µm) with an 18-min linear gradient from 5%
acetonitrile (0.1% formic acid) to 95% acetonitrile (0.1% formic acid). The mass spectra were recorded
in centroid mode (200 to 2000 m/z) at a scan rate of 2 Hz. Prior to analysis, all samples were dissolved
in methanol and centrifuged for 10 min at 4 ◦C and 15,000 rpm. The data were analyzed using
Bruker Compass Data Analysis 4.2. High-resolution masses were recorded on a Dionex Ultimate 3000
RSLC HPLC (Thermo Fisher Scientific) coupled with an LTQ Orbitrap (Thermo Fisher Scientific) on a
BEH C18 100 × 2.1 mm, 1.7-µm column (Waters) with an 18-min linear gradient from 5% acetonitrile
(0.1% formic acid) to 95% acetonitrile (0.1% formic acid). Data analysis was carried out using Xcalibur
3.0. Preparative HPLC was carried out using a Waters Autopurification System equipped with a Waters
2545 Binary Gradient module, a Waters System Fluidics Organizer (SFO), a Waters 2998 Photodiode
Array Detector (PAD), a Waters 2767 Sample Manager and a Waters SQ-Detector-2 on Nucleodur C18
Htec 250/21-C18 5 µm column (Macherey-Nagel, Düren, Germany). Data analysis was carried out using
MassLynx. Structural elucidation was carried out using nuclear magnetic resonance (NMR) technology.
The purified compounds were solved in 300 µL deuterated solvent (DMSO-d6, MeOD-d4, CDCl3)
and measured in a corresponding 5-mm Shigemi tube (DEUTERO GMBH; Kastellaun, Germany).
NMR data (1H, HH-COSY; TOCSY; HMBC, HSQC, 13C) were acquired either on a Bruker Ascend 700
spectrometer equipped with a 5-mm TXA Cryoprobe or a Bruker Avance 500 spectrometer equipped
with a 5-mm BBO Probe at 300 K (Bruker, BioSpin, GmbH, Rheinstetten, Germany). The data were
analyzed using Bruker’s TopSpin 3.5a software.
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2.2. In-Silico Analysis of Gene Clusters
The genome of Saccharothrix espanaensis was analyzed with antiSMASH [15] and the Geneious
software. Identified BGCs were mapped to the BAC library. A detailed analysis of 1E5′s BGC was
performed with BLAST [22].
2.3. Extraction, Dereplication and Isolation
The biomass was separated from the production medium (SG medium (20 g glucose, 5 g yeast
extract, 10 g bactosoytone, 2 g CaCO3 and 1000 mL H2Odest; pH = 7.2), 172 h, 29 ◦C, 180 rpm, pH = 7.2,
1% XAD-16 after 24 h) by centrifugation. Then, 20 mL of the supernatant was extracted with 20 mL
ethyl acetate followed by 20 mL butanol for 20 min using a Laboshake LS500 (C. Gerhardt GmbH,
Königswinter, Germany) at 160 rpm. The biomass was extracted with a 1:1 mixture of acetone and
methanol for 60 min. The solvents were evaporated until dry with a rotary evaporator (150 rpm, 60 ◦C,
240 mbar for ethyl acetate or 25 mbar for butanol) or under a nitrogen stream at 40 ◦C. The extracts
were analyzed using LC-MS and LC-HRMS. Singular peaks were compared to the databases Dictionary
of Natural Products, version 27.1 (CRC Press, Cleveland, OH, USA), Sci-Finder (CAS, Columbus, OH,
USA) and Chemspider (Royal Society of Chemistry, Raleigh, NC, USA). For production, 15 L of SG
medium inoculated with the corresponding recombinant strain was cultivated. The extracts were
evaporated to dryness and dissolved in 10 mL methanol. To purify single compounds, size exclusion
chromatography (SEC) was performed. The column was packed with 600 mL Sephadex LH-20 resin
(GE Healthcare Europe GmbH, 79,111 Freiburg, Germany) solved in methanol. At a flow rate of 10 mL
per 15 min, a fraction collector was used to separate the extract within 24 h. To identify fractions
containing the novel substances, every 4th fraction was analyzed by HPLC-MS. Fractions with the
corresponding mass were combined and evaporated. Prior to NMR analysis, a preparative HPLC
was performed. Preparative HPLC information can be found in Tables S3 and S4. NMR data of
pentangumycin (1) and SEK90 (2) can be found in Table 1.
Table 1. NMR spectroscopic data for pentangumycin (1) (DMSO-d6) and SEK90 (2) (DMSO-d6).
Pentangumycin (1) SEK90 (2)
Pos. δC δH (J in Hz) HMBC Pos. δC δH (J in Hz) HMBC
1 156.7 C - - 1 166.5 C - -
2 108.7 CH 7.10 s 1, 4, 12b, 19 2 102.7 C - -
3 143.2 C - - 3 165.5 C - -
4 117.5 CH 7.44 s 1, 2, 4a, 5, 12b, 19 4 101.9 CH 5.68 (s br) 2, 5, 6
4a 136.6 C - - 5 160.6 C - -
5 135.1 CH 7.88 s 1, 4, 4a, 6a, 7, 12a,12b, 13 6 36.1 CH2 3.55 (s br) 4, 5, 7, 8, 12
6 139.1 C - - 7 132.5 C - -
6a 131.2 C - - 8 120.1 CH 6.74 dd (7.7, N/A) 9, 10, 11, 12, 13
7 188.0 C - - 9 130.9 CH 7.2 dd (7.9, N/A) 7, 8, 10, 11, 12
7a 115.8 C - - 10 114.4 CH 6.77 dd (8.1, N/A) 8, 9, 11, 12, 13
8 160.5 C - - 11 153.3 C - -
9 123.0 CH 7.26 m 7a, 11 12 130.6 C - -
10 136.7 CH 7.73 t (7.5) 8, 11a 13 199.9 C - -
11 117.2 CH 7.50 dd (7.5, 0.93) 7a, 9, 10, 8, 12 14 115.3 C - -
11a 135.5 C - - 15 164.9 C - -
12 185.5 C - - 16 100.5 CH 6.11 d (2.4) 14, 15, 17
12a 140.0 C - - 17 166.3 C - -
12b 119.5 C - - 18 111.4 CH 6.04 dd (0.64, 2.4) 13, 14, 15, 16, 20
13 132.2 C - - 19 142.7 C - -
14/18 129.9 CH 7.26 m 6, 14/18, 16 20 21.2 CH3 1.8 s 14, 18, 19
15/17 114.8 CH 6.78 dt (8.5, 2) 13, 15/17, 16 21 29.5 CH 4.36 t (8.2) 1, 2, 3, 22, 23
16 156.6 C - - 22 31.5 CH2 1.75 dt (7.3, 8.2) 2, 21, 23, 24
19 42.4 CH2 4.43 d (6) 2, 3, 4, 20 23 20.6 CH2 1.05 dq (7.3) 21, 22, 24
20 169.6 C - - 24 13.8 CH3 0.89 t (7.3) 22, 23
21 22.8 CH3 1.93 s 20 - - - -
22 56.1 CH3 3.88 s 1 - - - -
NH - 8.53 t (br) 19, 20 - - - -
OH1 - - - - - 12.67 s 14, 15, 16
OH2 - - - - - 11.49 s (br) -
OH3 - - - - - 10.38 s 16, 18
OH4 - - - - - 9.78 s 10, 11, 12
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2.4. Modification of BACs
All constructed single knockout BACs were obtained by homologous recombination, as previously
described by Gust [14] and Myronovskyi [23], and confirmed by PCR. The recombinant BACs were
transformed into E. coli PUB307 and conjugated into S. lividans ∆YA6. All recombinant strains were
cultivated, and their metabolome was analyzed as described above.
2.5. Construction of Plasmids
For the construction of the plasmids pTOS_A3_R1 and pTOS_A3_R2, we amplified penR1
and penR2 using PCR and used the ordered oligonucleotides to introduce the sequence of the A3
promotor [24] and a KPNI restriction site in the 3′ oligonucleotide and a HindIII restriction site in
the 5′ oligonucleotide. The amplified PCR product and the integrative pTOS plasmid were cut using
HindIII and KPNI and ligated by the T4 ligase. The obtained DNA fragment was transformed into
E. coli PUB307 and conjugated into S. lividans ∆YA6. The backbone of pTOS was removed from the
genome by expression of pUWL_DRE containing the Dre recombinase.
Synthesis of 1E5_CMP1 and 1E5_CMP2
For the synthesis of 1E5_CMP1 and 1E5_CMP2, 6-benzyl-4-Hydroxy-2-pyrone (Wuxi AppTec,
Saint Paul, MN, USA) was used under the conditions described by de March. The pyrone was mixed
(2:1) with either butyraldehyde or formaldehyde in 3 mL ethanol containing 10 µL piperidine and
10 µL glacial acetic acid. The reaction was performed at room temperature for 24 h. All compounds
were purified using the Waters Autopurification System and confirmed by NMR.
Feeding experiments. To prove the incorporation from L-Phenylalanine, L-Tyrosine and
L-Tryptophan, a culture of either S. lividans ∆YA6_1E5 or S. lividans ∆YA6_1E5_A3_R1 was prepared
as described above. Thereafter, 10 mg of the labelled amino acid (either L-Phenylalanin, L-Tyrosine
or L-Tryptophan) was supplemented in 5 steps: 2 mg after 24, 48, 72, 96 and 120 h. After 164 h
of incubation, the supernatant of the production cultures was extracted and the incorporation was
quantified with LC-MS.
3. Results and Discussion
3.1. Selection of Putative Biosynthetic Gene Clusters
Initially, the biosynthetic potential of S. espanaensis (txid1179773) was assessed. An antiSMASH
analysis of its genome predicted the presence of 31 BGCs, while the only known products are
saccharomicins (Table S5) [19]. The BGC of saccharomicins was identified as cluster number 28 [18].
It was originally cloned as a cosmid clone by Berner et al., while attempts at its complete expression in
heterologous hosts had failed. Nevertheless, its aglycon was successfully expressed and its biosynthesis
was elucidated [25,26]. A bacterial artificial chromosome (BAC) library of S. espanaensis was constructed
using the pSMART-BAC-S vector as a backbone with an average inserted fragments size of 100 kb.
The library was end-sequenced, and the sequences were mapped to the genome of S. espanaensis.
This allowed the alignment of predicted BGCs to the clones of the genomic library. To minimize
the laboratory effort and reduce the putative rediscovery rate of natural products in the described
approach, BGCs were prioritized by their class and predicted products. Eight BGCs were not fully
covered by the genomic library and, therefore, could not be included into the laboratory approach.
The remaining 23 BGCs of the BAC library were composed of three BGCs that were predicted to produce
geosmin, melanin and bacteriocin and were, therefore, excluded. Three BGCs shared more than 75%
similarity to clusters of assigned products and were, therefore, not used for heterologous expression.
Finally, a predicted terpene cluster lacking its synthase and a lantipeptide BGC were excluded as
well. Thereafter, 15 remaining BACs covering 17 BGCs were selected for heterologous expression in
S. lividans ∆YA6 and S. albus J1074 (Table S5). Among the 17 BGCs, two were terpene clusters, five were
either type I or type II polyketide synthase (PKS) clusters, five were non-ribosomal peptide synthetase
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(NRPS) clusters, two were type I PKS/NRPS hybrid clusters, one was a lantipeptide cluster, one was an
aminoglycoside cluster and one was the polysaccharide cluster encoding saccharomicins BGC.
3.2. Success Rate of the Expression System
The chosen BACs were conjugated into S. lividans ∆YA6 and S. albus J1074. Every further-used
transconjugant was tested with colony polymerase chain reaction (PCR) for the presence of the
conjugated BAC. Verified transconjugants were cultivated in different production media and metabolites
were extracted using different solvents. Their metabolic profiles were analyzed with LC-MS and
compared to the metabolic profiles of the empty heterologous hosts. Singular peaks were identified
and assumed to be the products, shunt products or intermediates of the expressed BGC. Extracts
containing singular peaks were further analyzed by LC-HRMS, and the obtained exact masses were
compared to masses in common natural product databases (Dictionary of Natural Products (http:
//dnp.chemnetbase.com CRC Press, Cleveland, OH, USA), Supernatural [http://bioinf-applied.charite.
de/supernatural_new/index.php Charite University of Medicine, Berlin, Germany], StreptomeDB
[http://132.230.56.4/streptomedb/ University of Freiburg, Freiburg, Germany) [27,28].
The recombinant strain S. lividans ∆YA6_3C18, containing a 115-kb insert of the S. espanaensis
genome, revealed a singular peak (Figure S1) with a mass of 308.1987 Da (m/z 309.2060 [M+H]+,
Rt = 11.5 min). BAC clone 3C18 carries a type I PKS cluster similar to lavendiols BGC [29] and an
unknown NRPS BGC. The low production rate of the produced compound rendered isolation, structure-
and biosynthetic elucidation unfeasible. The expression of 3C18 was unsuccessful in S. albus J1074.
The recombinant strain S. lividans ∆YA6_1E5, containing a 116-kb insert from the genome of
S. espanaensis, produced two singular peaks with masses of 467.1368 (m/z 468.1438 [M+H]+, Rt = 9.1 min,
further designated as pentangumycin (1)) and 790.2261 Da (m/z 791.2339 [M+H]+, Rt = 10.6 min;
further designated as SEK90 (2)), as shown in Figure 2. S. albus J1074_1E5 produced compound 1
(Figure S2), but its low production titer rendered further work infeasible. Both compounds 1 and 2
have not been observed in extracts obtained from S. espanaensis (Figure S3).
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tRNA [32]. In S. lividans, the expression of a transglutaminase was increased by 73.6%, when using a
codon optimized gene for expression [33]. Thirdly, promotors and ribosomal binding sites not derived
from the native strain can be unfitting for the polymerase of the host strain and, therefore, disrupt the
expression of BGCs. The utilization of strong promotors can activate the expression of BGCs in native
and host strains. Salas et al. successfully activated the expression of an NRPS and PKS–NRPS hybrid
BGC by introducing the strong and constitutive ermE*p promotor in front of the NRPS (sshg_00313) and
PKS–NRPS (sshg_05713) genes. The activation of the NRPS BGC was confirmed by the production of a
blue pigment. Furthermore, they identified the natural products 6-epi-alteramid A and B, which were
produced by the PKS–NRPS BGC [34]. Fourthly, the toxicity of either expressed proteins or produced
natural products is an additional issue to keep in mind when expressing BGCs in heterologous hosts.
For example, a mutated version of an outer membrane protein (OmpA) of E. coli K12 caused a toxic
lysis of the cell when expressed [35]. Furthermore, the toxicity of avermectin was shown to be a
restrictive factor in its own production in S. avermitilis. After the introduction of multiple copies of
the ABC transporter AvtAB, the avermectin production increased from 3.3 to 4.8 g/L [36]. Finally,
environmental factors can drastically influence the production of natural products. A well-studied
example is the production of jadomycin, since it was only produced after the strain was either treated
with a heat shock or the production medium was supplemented with ethanol [37]. Furthermore, it has
been proven that the addition of sugars [38] and sub-toxic concentrations of antibiotics can activate
and strongly alter the expression of BGCs in bacteria [39,40].
3.3. Isolation of Pentangumycin and SEK90
Ultimately, 3.5 mg of pentangumycin 1 and 14 mg of SEK90 2 were isolated from 15 L of a S. lividans
∆YA6_1E5 production culture. Both compounds were purified using size exclusion chromatography
and preparative HPLC. Through analysis of LC-HRMS data and NMR data (1H-NMR, HSQC, HMBC,
1H-1H-COSY, 13C-NMR), the structures of both compounds were elucidated (Figure 2). NMR data and
the detailed data analysis are presented in Table 1 and Figures S4–S50. All chemical shifts observed
for 1 were within expected ranges as calculated for its structure. The connection between rings E
and B was observed through HMBC correlations between H-5 and C-13 and between H-14/H-18
and C-6 (Figure 2, Figure S4). Compound 1 is a member of the angucyclinone group containing a
unique fifth phenol ring attached through a direct carbon–carbon bond at position C-6. Additional
ring systems, typically derived from amino acids, have previously been observed in the angucycline
family of aromatic polyketides. While such structures have been found in several jadomycins and
urdamycins, their position and type of connection are different [41–43]. Additionally, formicamycins
and fasamycins, which are examples of anthracycline antibiotics, carry a similar structural motif with
the fifth aromatic ring at position C-7 of ring B [44]. Furthermore, 1 has a methylated hydroxy group
at position C-1 in ring A, a modification that can be found only in a few angucyclines, such as the
chlorocyclinones [45]. In addition, the drastic structural feature of 1 is the presence of an aminated and,
subsequently, the acetylated methyl group at position C-19, which has not been previously reported.
The biological activity of 1 and 2 was tested. Both compounds showed no significant antimicrobial
and anticancer activity. In a CAS assay, compound 2 showed low iron-binding siderophore activity [46].
The NMR spectra of 2 contained less carbon and proton signals than anticipated regarding its
observed exact mass. The 1H-NMR signal of H-21 (CH) indicated the presence of a mirror plane,
since all other integrated proton signals were a multiple of one (2–6). Another strong indicator was the
low number of carbon peaks observed in the 13C-NMR (24 peaks in 13C-NMR), which only sums up to
the corresponding exact mass of 2 with an unreasonable number of incorporated heteroatoms. After the
identification of the mirror plane, the monomer SEK43 (Figure S51) could easily be elucidated [47].
The protons H-16, H-18 and H-20 as well as H-6, H-8, H-9 and H-10 showed all necessary HMBC and
1H–1H–COSY correlations for the elucidation of their corresponding aromatic system. The connecting
ketone moiety was elucidated through the correlations of H-18 and H-10 to C-13 and the carbon shift
of C-13 (199.9 ppm). The pyrone moiety of SEK43 was elucidated through correlations between H-6
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to C-5 and C-4, H-4 to C-1, C-2, C-4 and C-6, H-21 to C-1 and C-3 and H-22 to C-2. The connecting
butyl group showed all expected 1H–1H–COSY and HMBC correlations (Figure S28). The putative
axial stereochemistry of 2 can be assumed to be a racemic mixture due to its spontaneous formation as
described below.
3.4. Both 1 and 2 Are the Result of Type II PKS Gene Cluster Expression
The antiSMASH analysis of the sequence of BAC 1E5 revealed the presence of three putative
BGCs: a terpene cluster, a type-II PKS and a PKS–NRPS hybrid. From a structural perspective, it is
obvious that neither 1 nor 2 are products of the terpene BGC and that 1 is a product of the type II
polyketide synthase. However, 2 cannot easily be associated with the type II PKS or the PKS–NRPS
hybrid. Even though the SEK43 moiety of 2 is a known shunt product of type II polyketide synthases,
the connection through a butyl group has never been reported. To verify the biosynthetic origins
of 1 and 2, we aimed to identify the core genes of the corresponding BGCs and deleted them from
BAC 1E5. A BLAST analysis of the type II PKS BGC showed that gene BN6_54860 is coding for a
β-ketoacyl-synthase (Figure 3) and gene BN6_55110 is encoding a type I polyketide synthase in the
PKS–NRPS BGC. Both genes were deleted separately in frame from BAC 1E5. The resulting BACs,
1E5∆54860 and 1E5∆55110, were conjugated into S. lividans ∆YA6, and the metabolic profiles of both
recombinant strains were analyzed. The production in the strain carrying mutant BAC 1E5∆55110
remained unchanged, whereas the deletion of gene BN6_54860 resulted in the loss of production of 1
and 2 (Figure S52). This clearly proves the origin of both compounds to be the type II PKS gene cluster.
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3.5. Detailed Analysis and Border Prediction of the Biosynthetic Gene Cluster of Pentangumycin
The putative borders of pentangumycin’s B ( IBiG accession number: BGC0002070) are
defined by the genes BN6_54730 (further as penA) on the left edge and BN6_54950 (further as penR2) on
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the right (Figure 3a). To predict their functions, individual pen genes were analyzed using BLASTx.
Detailed results are illustrated in Figure 3b. The core of the pen cluster is formed by genes penM, penN
and penO, coding for the minimal polyketide synthase. Together with two cyclase genes, penL and penF,
the cyclase/aromatase penQ and the ketoreductase penP are forming a minimal set of genes required for
the biosynthesis of the angucyclinone backbone. The polyketide core region is surrounded by seven
genes putatively involved in oxidative or reductive reactions. The gene penA encodes a cytochrome
P450 enzyme and is adjacent to penB, which encodes a ferredoxin protein. Both genes have previously
been described as a functional unit [48–50]. The genes penE, penG, penI, penS and penT encode a
monooxygenase (penE), three oxidoreductases (penG, penI and penS) and an aldo-/ketoreductase (penT).
Except for PenE, PenS and PenT, the function of these enzymes cannot be predicted from the BLAST
analysis. penE, penS and penT encode orthologues of JadG, JadF and JanH, respectively, which are three
enzymes putatively involved in the oxidative opening of ring B of jadomycin [51]. Other genes such
as penC (encoding putative aminotransferase) and penD (encoding putative methyltransferase) are
also supposed to be involved in post-PKS modifications of 1. penK, penU and penV encode α-, β- and
ε-subunits of a carboxyltransferase, respectively. The function of these enzymes in the biosynthesis
of 1 is unclear. Two regulatory genes—penR1, encoding a putative transcriptional regulator with
the predicted helix-turn-helix motif at the N-terminus, and penR2, coding for a SARP protein—are
present in the cluster [52]. PenR1 most probably controls the transcription of the outward-oriented
penH (Figure 3), similar to the landomycins lanK, lanJ regulatory system [53–55]. The gene penH
encodes a putative major facilitator superfamily transporter [56]. In turn, PenR2 shows a high degree
of similarity compared to many well-studied SARP proteins from angucycline biosynthetic gene
clusters, including JadR1 from S. venezuelae [52]. Due to the similar structures of 1 and landomycin and
jadomycin [41,57], we aimed to identify homologues to genes involved in the biosynthetic pathways of
both aforementioned compounds within the pen gene cluster. The PKS core genes penL, penN, penO,
penP and penQ showed a significant similarity towards the landomycin biosynthetic genes lanL, lanA,
lanB, lanC and lanD, respectively (Figure 3b). The oxygenase penE and the oxidoreductases penS and
penT showed a remarkable homology to the oxidase jadG and the oxidoreductases jadF and jadH,
respectively [58]. Additionally, a similarity between individual genes including penA, penB, penC,
penD and penH including their organization and the putative biosynthetic gene cluster with unknown
product from Micromonospora sp. LB39 was observed (Figure 3b and Figure S53).
We aimed to confirm the predicted borders (penA and penR2) of pentangumycins biosynthetic
gene cluster. Therefore, two BACs (1E5_DEL_LEFT and 1E5_DEL_RIGHT) were designed.
BAC 1E5_DEL_LEFT was constructed through deletion of 44.1 kb covering the left flanking region
of the pen cluster upstream from the gene penA (Figure 3a), including the entire terpene cluster.
The construction of 1E5_DEL_RIGHT was carried out in a similar way by deleting a 36.3-kb
large region downstream to the penR2 gene, including the entire predicted PKS–NRPS gene cluster.
The constructed BACs were conjugated into S. lividans ∆YA6, and the production of 1 was analyzed.
The recombinant strains carrying the mutated BACs still produced 1. Deletions of the terminal genes
penA and penR2 caused complete cessation of pentangumycin biosynthesis in the recombinant strains
carrying corresponding BAC clones 1E5∆penA and 1E5∆penR2. The metabolic profiles of S. lividans
transconjugants showed that both genes are required for production of 1. These findings confirm that
all genes necessary for the production of 1 are within the predicted borders of the pen gene cluster.
3.6. Biosynthesis of Pentangumycins Core Structure
Based on the available bioinformatic information described above (Figure 3b) and our experimental
results, a biosynthetic route towards 1 was proposed (Figure 4) [59,60]. PenM, PenN and PenO utilize
acetyl-CoA and malonyl-CoA to form the initial 20 carbon polyketide chain, which is reduced at
position C-9 by PenP and cyclized by PenL and PenQ. Like in the case of all other angucycline
type aromatic polyketides, the biosynthesis of 1 seems to proceed though the common intermediate
UWM6 [57]. UWM6 is oxidized by PenE, PenS [60] and PenT, which leads to the formation of I [58].
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The cleavage of ring B undergoes a Baeyer–Villiger oxidation through the putative intermediates II and
III. The latter one is proposed to have an aldehyde functional group at position C-5 and a carboxyl group
at position C-6. Similar to dauD in daunomycin biosynthesis, the ester cyclase PenF could perform a
Knoevenagel condensation, which results in the formation of the C-C bond between the β-position of
4-hydroxyl-phenylpyruvic acid, an intermediate of the tyrosine degradation catalyzed by an aromatic
amino acid transaminase [61], and the aldehyde of III, resulting in intermediate IV. An intramolecular
nucleophilic reaction between the γ-hydroxyl and the α-keto groups cleaves oxalic acid and thus
creates a double bond between the former β and γ positions and a conjugated system. The subsequent
reformation of ring B is catalyzed by the decarboxylation at position C-5 and directed through
the six-membered transition state towards the former β-position of the 4-hydroxyl-phenylpyruvic
acid, leading to intermediate V. The aromatase/cyclase PenQ is proposed to be responsible for the
aromatization of ring B, resulting in intermediate VI. To prove that the fifth ring of 1 derives from the
incorporation of 4-hydroxyl-phenylpyruvic acid, a culture of S. lividans ∆YA6_1E5 was supplemented
with fully labeled 13C-9-15N L-tyrosine. As a result, a mass shift to m/z 475 [M+H]+ was observed for
the peak that corresponds to 1 (Figures S72–S77). This shift clearly shows that the fifth ring of 1 derives
from incorporation of L-tyrosine, as it is in the case of jadomycin, and not from acetate, as it was shown
for formicamycin [44]. Furthermore, the lack of two tyrosine-derived carbons in the final structure
shows that the insertion of the fifth ring most probably occurs by the proposed mechanism with the
loss of α- and β-carbons of tyrosine and the exchange of carbon six of IV with one of L-tyrosine’s in
the re-cyclization process (Figure 4).
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3.7. Tailoring Steps of Pentangumycin’s Biosynthesis
To elucidate the role of the remaining genes encoding the putative tailoring enzymes involved in
post PKS modifications of 1, a set of single knockout mutant BACs (1E5∆penA; 1E5∆penC; 1E5∆penD;
1E5∆penE, 1E5∆penG; 1E5∆penI; 1E5∆penJ; 1E5∆penU; 1E5∆penV) was created and expressed in
S. lividans ∆YA6. The production of 1 was not affected by deletions of penG, penI, penJ, penU and penV
genes from BAC 1E5. At the same time, recombinant strains carrying 1E5 with deleted penA, penC,
penD and penE genes lack the production of 1, but were found (except penE mutant) to accumulate
related angucyclinone compounds based on optical absorption and mass spectrometry data (Figure 4)
The inactivation of penA resulted in the production of a new compound with m/z 411.1218 [M+H]+
that is very close to the calculated exact mass of 410.1154 Da of proposed intermediate 3 (∆2.190 ppm)
(Figure S78). The deletion of penC led to accumulation of the proposed intermediate 4 (detected m/z
427.1174 [M+H]+, calculated mass of 426.1103 Da, ∆0.409 ppm) (Figure S79). The BAC lacking penD gene
facilitated the production of another compound with m/z 454.1278 [M+H]+ that corresponds to the mass
of the proposed intermediate 5 (calculated exact mass of 453.1212, ∆1.506 ppm) (Figure S80). With the
information gained from the analysis of all metabolic profiles from the recombinant strains carrying 1E5
with deletion of the aforementioned genes, it can be hypothesized that PenA catalyzes a hydroxylation
of the methyl group at position C-19 to form a primary alcohol. The alcohol is subsequently oxidized
by one of the oxidoreductases to an aldehyde, resulting in predicted intermediate VII. A similar
biosynthetic reaction was proposed for the borrelidin biosynthetic pathway [62]. PenC performs an
amination of the aldehyde at this position, resulting in structure VIII. However, in the extract of
S. lividans ∆YA6_1E5∆penC, only proposed intermediate 4 can be found, most probably because the
aldehyde of VII is not stable and is spontaneously reduced to an alcohol. Lastly, the deletion of penD
leads to accumulation of 5, the last intermediate before formation of 1 lacking methylation of the
hydroxyl group at position C-1 (Figure 4). The presence of this intermediate, as well as methylated 3
and 4, makes us believe that PenD can act on both substrates 5 and VI as well as that the presence of a
methyl group at this position is not crucial for amination and acylation events.
The deletion of penE leads to a complete loss of production of 1. Interestingly, the shunt product
rabelomycin [63] can be identified in all of our extracts obtained from knockout mutants (identified
with an external standard), but its production is drastically reduced in the extracts of S. lividans
∆YA6 1E5∆penE (Figure S81). This result indicates an involvement of penE in the early steps of the
biosynthesis of 1.
3.8. Analysis of Regulatory Gene Functions
To elucidate the functions of the identified regulatory genes on the biosynthesis of 1, we constructed
recombinant BACs with deletions of penR1 and penR2. Both BACs were conjugated into S. lividans ∆YA6.
The constructed recombinant strains S. lividans ∆YA6 1E5_∆penR1 and S. lividans ∆YA6 1E5_∆penR2
were analyzed for production of 1 (Figure S82). While 1 was still detectable in the ∆penR1 mutant with
a 50-fold decrease in yield, it was no longer present in the S. lividans ∆YA6 1E5_∆penR2 extracts. From
this observation and high similarity of penR2 to other SARP-encoding genes, it becomes obvious that
this gene is encoding a pathway-specific regulator controlling the expression of structural pen genes.
Furthermore, the overexpression of either penR1 or penR2 might lead to the increase in the production
of 1. To test this hypothesis, both genes were cloned under the control of the moderately strong A3
promoter [24] and introduced into S. lividans ∆YA6 using a marker-free vector system [64]. The resulting
strains S. lividans ∆YA6_A3_penR1 and S. lividans ∆YA6_A3_penR2 were tested for the production of
1 and 2. Surprisingly, the production level of 1 remained unchanged in both strains (Figure S83). S.
lividans ∆YA6_A3_penR1 1E5 still produced 2, but 2 was absent in extracts of S. lividans ∆YA6_A3_penR2
1E5 (Figure S84). These results indicate an interdependence between the two regulatory elements,
similar to the promoter effects observed in the production of bottromycin, and lead to the conclusion
that the unbalanced expression of pentangumycin’s BGC is indeed the reason for accumulation of
SEK90 and its derivatives by the heterologous strain carrying BAC 1E5 [65]. Furthermore, two novel
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peaks, 6 and 7, were detected in the extract of S. lividans ∆YA6_A3_penR1 1E5 (Figure S85). Based on
LC-HRMS data, 6 could be proposed to be an analogue of 1 with tryptophan incorporated into ring B
instead of tyrosine (detected m/z 491.15934 [M+H]+, calculated exact mass of 490.1529 Da, ∆1.646),
while 7 seems to carry phenylalanine-derived moiety at the same position (detected m/z 452.14903
[M+H]+, calculated exact mass 451.1419 Da, ∆0.485 ppm) (Figure S85). To prove the possible nature of
the identified derivatives 6 and 7, the culture of S. lividans ∆YA6_A3_penR1 1E5 was supplemented with
either L-tryptophan (13C11H12N2O2) or L-phenylalanine (ring-D5). As result, in the correspondingly
fed cultures, the mass of 6 shifted to m/z 500.19 [M+H]+ (Figure S86), and the mass of 7 shifted to m/z
457.20 [M+H]+ (Figure S87), which corresponds to the incorporation of labelled L-tryptophan and
labelled L-phenylalanine.
3.9. Origin of SEK90
From a structural perspective, 2 is a dimer of SEK43 linked by a butyl group. It was shown by
McDaniel that SEK43 is formed by spontaneous cyclization of the polyketide chain in mutants lacking
the cyclase [47]. Since then, SEK43 has been reported as a shunt product in several studies of aromatic
polyketide cyclases/aromatases [66–68]. At the same time, SEK43 was found in the extract of natural
strains only in the case of the aranciamycin-producing Streptomyces sp. Tü6384 [69]. On the other hand,
its derivative, named SEK43F, resulting from fusion of SEK43 with the pyrole-like moiety, was isolated
from the recombinant S. albus expressing fluostatin biosynthetic gene cluster [70]. Nevertheless,
a dimerization of this compound has not been described thus far. SEK43 has the 4-hydroxypyrone
structural motif. The reactivity of 4-hydroxypyrones towards saturated aldehydes was reported
previously [71]. It can be hypothesized that dimerization towards SEK90 can occur spontaneously
inside the cell after the biosynthetic formation of SEK43 (Figure 5). To verify this theory, an experimental
setup was designed; 6-Benzyl-4-hydroxy-2-pyrone that possesses the same structural motif as SEK43
was incubated with butanal or formaldehyde in distilled water, production medium inoculated with
S. lividans ∆YA6 and production medium inoculated with S. lividans ∆YA6_1E5. If the dimerization of
the pyrone with the corresponding aldehyde is performed by an enzymatic reaction, the expected dimers
(1E5_CMP1, further designated as 8, and 1E5_CMP2, further designated as 9; see Figure S51) should
only be present in the extracts of S. lividans ∆YA6 or S. lividans ∆YA6_1E5, depending on the presence
of the necessary enzymes in the heterologous host or the introduced BAC. If the reaction towards 2 is
spontaneous, the dimerization of pyrone and aldehydes should occur in the distilled water mixture.
After incubation, all reactions were extracted and analyzed with LC-HRMS. Peaks that correspond to
dimerized pyrones were present in all mixtures, including the distilled water-based one, confirming
our hypothesis about the spontaneous nature of the 4-hydroxypyrone dimerization. Furthermore,
we have synthesized 8 and 9 to verify their structure by NMR (Tables S6 and S7; Figures S54–S70) [71].
The peaks observed in the distilled water mixtures had identical exact masses and HPLC retention
times as the synthesized standards (Figures S71 and S72). Detailed analysis of the S. lividans ∆YA6 1E5
extract revealed the presence of SEK43 (detected m/z 396.09679 [M+H]+, ∆0.242 ppm to SEK43 with
the calculated exact mass of 368.0860 Da) (Figures S51 and S73) and a derivative of SEK90 connected
by a methyl- instead of a butyl group named as SEK87 (detected m/z 749.1859 [M+H]+, ∆0.777 ppm
to SEK87 with the calculated exact mass of 748.1792 Da) (Figures S51 and S74). None of the three
compounds can be found in the extract of S. espanaensis. Thus, it is obvious that SEK90 as well as
SEK87 derives from the combination of an unbalanced performance of pentangumycins minimal PKS,
which seems to be uncoordinated with the activity of the Pen cyclases, leading to accumulation of
SEK43 and the primary metabolism of S. lividans. A similar situation was proposed for the assembly of
SEK43F, which resulted from interplay between the primary metabolism of the host strain S. albus and
the heterologously expressed fluostatins type II PKS gene cluster [70].
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